Urinary tract infection pathogenesis. Host factors

Infectious Disease Clinics of North America

Volumn 28, Issue 1, 2014, Pages 149-159

  Stapleton, Ann E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Estrogen status; Female gender; Modifiable host factors; Nonmodifiable host factors; Sexual intercourse; Urogenital microbiota

Indexed keywords

ANTIINFECTIVE AGENT; COTRIMOXAZOLE; ESTROGEN; PROBIOTIC AGENT;

ANATOMY; BACTERIAL UROPATHOGENESIS; CLINICAL FEATURE; CONTRACEPTIVE BEHAVIOR; DISEASE COURSE; ENTEROBACTERIACEAE; FECES MICROFLORA; FUNCTIONAL DISEASE; GENDER; HEALTH BEHAVIOR; HEREDITY; HOST PATHOGEN INTERACTION; HUMAN; INFECTION COMPLICATION; INFECTION RISK; INNATE IMMUNITY; LABORATORY TEST; LACTOBACILLUS; MICROBIAL ACTIVITY; MICROFLORA; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; POSTMENOPAUSE; REVIEW; RISK MANAGEMENT; RISK REDUCTION; SEXUAL INTERCOURSE; SYMPTOM; URINARY TRACT FUNCTION; URINARY TRACT INFECTION; UROGENITAL MICROBIOTA;

EID: 84895074966     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2013.10.006     Document Type: Review

References (71)

1. Schappert S.M., Rechtsteiner E.A. Ambulatory medical care utilization estimates for 2007. Vital Health Stat 13 2011, (169):1-38.
2. Foxman B., Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am 2003, 17(2):227-241.
3. Hooton T. The current management strategies for community-acquired urinary tract infection. Infect Dis Clin North Am 2003, 17:303-332.
4. Hooton T.M. Clinical practice. Uncomplicated urinary tract infection. NEngl J Med 2012, 366(11):1028-1037.
5. Nicolle L.E. Complicated urinary tract infection in adults. Can J Infect Dis Med Microbiol 2005, 16(6):349-360.
6. Ragnarsdottir B., Svanborg C. Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections. Pediatr Nephrol 2012, 27(11):2017-2029.
7. Hooton T.M., Scholes D., Hughes J.P., et al. Aprospective study of risk factors for symptomatic urinary tract infection in young women. NEngl J Med 1996, 335(7):468-474.
8. Johnson J. Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect Dis Clin North Am 2003, 17:261-278. viii.
9. Stapleton A.E. Urinary tract infection in women: new pathogenic considerations. Curr Infect Dis Rep 2006, 8(6):465-472.
10. Nielubowicz G.R., Mobley H.L. Host-pathogen interactions in urinary tract infection. Nat Rev Urol 2010, 7(8):430-441.
11. Brumbaugh A.R., Mobley H.L. Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines 2012, 11(6):663-676.
12. Hooton T.M., Hillier S., Johnson C., et al. Escherichia coli bacteriuria and contraceptive method. JAMA 1991, 265(1):64-69.
13. Scholes D., Hooton T.M., Roberts P.L., et al. Risk factors for recurrent urinary tract infection in young women. JInfect Dis 2000, 182(4):1177-1182.
14. Stapleton A., Latham R.H., Johnson C., et al. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial. JAMA 1990, 264(6):703-706.
15. Smith H.S., Hughes J.P., Hooton T.M., et al. Antecedent antimicrobial use increases the risk of uncomplicated cystitis in young women. Clin Infect Dis 1997, 25(1):63-68.
16. Beerepoot M.J., ter Riet G., Nys S., et al. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. Arch Intern Med 2011, 171(14):1270-1278.
17. Costelloe C., Metcalfe C., Lovering A., et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010, 340:c2096.
18. Paschke A.A., Zaoutis T., Conway P.H., et al. Previous antimicrobial exposure is associated with drug-resistant urinary tract infections in children. Pediatrics 2010, 125(4):664-672.
19. Hooton T.M., Stamm W.E. The vaginal flora and urinary tract infections. Urinary tract infections: molecular pathogenesis and clinical management 1996, 67. ASM Press, Washington, DC. J.W. Warren, H.L. Mobley (Eds.).
20. Pfau A., Sacks T. The bacterial flora of the vaginal vestibule, urethra and vagina in premenopausal women with recurrent urinary tract infections. JUrol 1981, 126(5):630-634.
21. Stamey T.A., Sexton C.C. The role of vaginal colonization with Enterobacteriaceae in recurrent urinary tract infections. JUrol 1975, 113:214-217.
22. 2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. JInfect Dis 1998, 178(2):446-450.
23. Hooton T.M., Fihn S.D., Johnson C., et al. Association between bacterial vaginosis and acute cystitis in women using diaphragms. Arch Intern Med 1989, 149(9):1932-1936.
24. Hooton T.M., Roberts P.L., Stamm W.E. Effects of recent sexual activity and use of a diaphragm on the vaginal microflora. Clin Infect Dis 1994, 19(2):274-278.
25. Antonio M.A., Hawes S.E., Hillier S.L. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. JInfect Dis 1999, 180(6):1950-1956.
26. Ravel J., Gajer P., Abdo Z., et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 2011, 108(Suppl 1):4680-4687.
27. Zhou X., Brown C.J., Abdo Z., et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J 2007, 1(2):121-133.
28. Zhou X., Hansmann M.A., Davis C.C., et al. The vaginal bacterial communities of Japanese women resemble those of women in other racial groups. FEMS Immunol Med Microbiol 2010, 58(2):169-181.
29. Hawes S.E., Hillier S.L., Benedetti J., et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. JInfect Dis 1996, 174:1058-1063.
30. Martin H.L., Richardson B.A., Nyange P.M., et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. JInfect Dis 1999, 180(6):1863-1868.
31. Schwebke J.R. Role of vaginal flora as a barrier to HIV acquisition. Curr Infect Dis Rep 2001, 3(2):152-155.
32. Taha T.E., Hoover D.R., Dallabetta G.A., et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998, 12(13):1699-1706.
33. van De Wijgert J.H., Mason P.R., Gwanzura L., et al. Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women. JInfect Dis 2000, 181(2):587-594.
34. 2-producing lactobacilli on Neisseria gonorrhoeae growth and catalase activity. JInfect Dis 1994, 170(5):1209-1215.
35. Boris S., Barbes C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect 2000, 2(5):543-546.
36. Herthelius M., Gorbach S.L., Mollby R., et al. Elimination of vaginal colonization with Escherichia coli by administration of indigenous flora. Infect Immun 1989, 57(8):2447-2451.
37. McGroarty J.A., Reid G. Detection of a Lactobacillus substance that inhibits Escherichia coli. Can J Microbiol 1988, 34(8):974-978.
38. McGroarty J.A., Tomeczek L., Pond D.G., et al. Hydrogen peroxide production by Lactobacillus species: correlation with susceptibility to the spermicidal compound nonoxynol-9. JInfect Dis 1992, 165(6):1142-1144.
39. Osset J., Bartolome R.M., Garcia E., et al. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. JInfect Dis 2001, 183(3):485-491.
40. Reid G., Cook R.L., Bruce A.W. Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. JUrol 1987, 138(2):330-335.
41. Reid G., Heinemann C., Velraeds M., et al. Biosurfactants produced by Lactobacillus. Meth Enzymol 1999, 310:426-433.
42. Stamey T.A., Kaufman M.F. Studies of introital colonization in women with recurrent urinary infections. II. A comparison of growth in normal vaginal fluid of common versus uncommon serogroups of Escherichia coli. JUrol 1975, 114(2):264-267.
43. Schaeffer A.J., Jones J.M., Amundsen S.K. Bacterial effect of hydrogen peroxide on urinary tract pathogens. Appl Environ Microbiol 1980, 40(2):337-340.
44. 2-generating lactobacilli. JInfect Dis 1991, 164:94-100.
45. Hooton T.M., Fennell C.L., Clark A.M., et al. Nonoxynol-9: differential antibacterial activity and enhancement of bacterial adherence to vaginal epithelial cells. JInfect Dis 1991, 164(6):1216-1219.
46. Hooton T.M., Scholes D., Gupta K., et al. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA 2005, 293(8):949-955.
47. Hooton T.M., Roberts P.L., Stapleton A.E. Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial. JAMA 2012, 307(6):583-589.
48. Gupta K., Hooton T.M., Naber K.G., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011, 52(5):e103-e120.
49. Raz R. Urinary tract infection in postmenopausal women. Korean J Urol 2011, 52(12):801-808.
50. Grin P.M., Kowalewska P.M., Alhazzan W., et al. Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis. Can J Urol 2013, 20(1):6607-6614.
51. Stapleton A., Moseley S., Stamm W.E. Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women. JInfect Dis 1991, 163(4):773-779.
52. Czaja C.A., Stamm W.E., Stapleton A.E., et al. Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. JInfect Dis 2009, 200(4):528-536.
53. Hooton T.M. Recurrent urinary tract infection in women. Int J Antimicrob Agents 2001, 17(4):259-268.
54. Russo T.A., Stapleton A., Wenderoth S., et al. Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. JInfect Dis 1995, 172(2):440-445.
55. Beerepoot M.A., ter Riet G., Nys S., et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med 2012, 172(9):704-712.
56. Hannan T.J., Totsika M., Mansfield K.J., et al. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev 2012, 36(3):616-648.
57. Rosen D.A., Hooton T.M., Stamm W.E., et al. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 2007, 4(12):e329.
58. Luthje P., Brauner H., Ramos N.L., et al. Estrogen supports urothelial defense mechanisms. Sci Transl Med 2013, 5(190):190ra180.
59. Matlaga B.R. How do we manage infected, obstructed hydronephrosis?. Eur Urol 2013, 64(1):93-94.
60. Sammon J.D., Ghani K.R., Karakiewicz P.I., et al. Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United States. Eur Urol 2013, 64(1):85-92.
61. Marschall J., Zhang L., Foxman B., et al. Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients. Clin Infect Dis 2012, 54(12):1692-1698.
62. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 2003, 49(2):53-70.
63. Jackson S.L., Boyko E.J., Scholes D., et al. Predictors of urinary tract infection after menopause: a prospective study. Am J Med 2004, 117(12):903-911.
64. Stamm W.E., McKevitt M., Roberts P.L., et al. Natural history of recurrent urinary tract infections in women. Rev Infect Dis 1991, 13:77-84.
65. Scholes D., Hooton T.M., Roberts P.L., et al. Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med 2005, 142(1):20-27.
66. Scholes D., Hawn T.R., Roberts P.L., et al. Family history and risk of recurrent cystitis and pyelonephritis in women. JUrol 2010, 184(2):564-569.
67. Hawn T.R., Scholes D., Li S.S., et al. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One 2009, 4(6):e5990.
68. Hawn T.R., Scholes D., Wang H., et al. Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women. PLoS One 2009, 4(12):e8300.
69. Ragnarsdottir B., Samuelsson M., Gustafsson M.C., et al. Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. JInfect Dis 2007, 196(3):475-484.
70. Hooton T.M., Scholes D., Stapleton A.E., et al. Aprospective study of asymptomatic bacteriuria in sexually active young women. NEngl J Med 2000, 343(14):992-997. [see comments].
71. McDaniel D.O., Rigney D.A., McDaniel K.Y., et al. Early expression profile of inflammatory markers and kidney allograft status. Transplant Proc 2013, 45(4):1523.